TY - JOUR
T1 - Highly sensitive C-reactive protein in metabolic syndrome
AU - Vidyasagar, Sudha
AU - Abdul Razak, U. K.
AU - Prashanth, C. K.
AU - Muralidhar Varma, D.
AU - Bairy, K. L.
PY - 2013/10/16
Y1 - 2013/10/16
N2 - Background: Metabolic syndrome is known to predispose to atherosclerosis. C-reactive protein, a marker of systemic inflammation is significantly associated with the atherosclerotic process. Methods: We prospectively studied the relationship between high-sensitivity C-reactive protein (hs-CRP) with various components of metabolic syndrome in 91 patients with metabolic syndrome at our tertiary care centre in South India. Results: The mean age of patients was 57.5 ± 9.8 years; there were 67 (73.6%) males. On univariate analysis, hs-CRP was found to be significantly increased in patients with diabetes mellitus (p < 0.021) and those with abnormal waist circumference (p<0.003). There was no significant association between hs-CRP and high triglycerides, hypertension, and reduced high density lipoprotein cholesterol. Further, hs-CRP increased significantly with increasing number of components of metabolic syndrome (p< 0.008). Conclusions: Measurement of hs-CRP can be used as a surrogate marker of chronic inflammation in patients with metabolic syndrome.
AB - Background: Metabolic syndrome is known to predispose to atherosclerosis. C-reactive protein, a marker of systemic inflammation is significantly associated with the atherosclerotic process. Methods: We prospectively studied the relationship between high-sensitivity C-reactive protein (hs-CRP) with various components of metabolic syndrome in 91 patients with metabolic syndrome at our tertiary care centre in South India. Results: The mean age of patients was 57.5 ± 9.8 years; there were 67 (73.6%) males. On univariate analysis, hs-CRP was found to be significantly increased in patients with diabetes mellitus (p < 0.021) and those with abnormal waist circumference (p<0.003). There was no significant association between hs-CRP and high triglycerides, hypertension, and reduced high density lipoprotein cholesterol. Further, hs-CRP increased significantly with increasing number of components of metabolic syndrome (p< 0.008). Conclusions: Measurement of hs-CRP can be used as a surrogate marker of chronic inflammation in patients with metabolic syndrome.
UR - http://www.scopus.com/inward/record.url?scp=84885365115&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885365115&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84885365115
SN - 0972-3560
VL - 14
SP - 230
EP - 234
JO - Journal, Indian Academy of Clinical Medicine
JF - Journal, Indian Academy of Clinical Medicine
IS - 3-4
ER -